Questor: How to turn blood into gold [Yahoo! Finance]
ADMA Biologics Inc (ADMA)
Last adma biologics inc earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.admabiologics.com
Company Research
Source: Yahoo! Finance
A growing collection of companies, for example, have learned how to extract elements of our blood that contain powerful antibodies, which can be used to huge therapeutic benefit by those who otherwise lack them. One increasingly significant player in this growing market is Adma Biologics, a US-based biopharmaceuticals business that has turned blood plasma into effective treatments against infectious diseases for patients with compromised immune systems. Plasma, the liquid in which blood cells are suspended, is rich in proteins and immune globulins used by the body to prevent clots and fight off infections. Adma has developed and commercialised three products that can be employed to ward off hundreds of illnesses to which the immuno-compromised are particularly susceptible, including Hepatitis B. Unsurprisingly, Adma Biologics is not the only company of its kind but it does have some specific characteristics that give it a competitive edge. It is rare, for instance, in that it i
Show less
Read more
Impact Snapshot
Event Time:
ADMA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADMA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADMA alerts
High impacting ADMA Biologics Inc news events
Weekly update
A roundup of the hottest topics
ADMA
News
- ADMA Biologics, Inc. (NASDAQ: ADMA) had its price target raised by analysts at HC Wainwright from $18.00 to $26.00. They now have a "buy" rating on the stock.MarketBeat
- ADMA Biologics, Inc. (NASDAQ: ADMA) had its price target raised by analysts at Raymond James from $18.00 to $25.00. They now have a "strong-buy" rating on the stock.MarketBeat
- ADMA Investors Have Opportunity to Join ADMA Biologics, Inc. Fraud Investigation with the Schall Law FirmPR Newswire
- ADMA INVESTOR NEWS: ADMA Biologics Investors with Losses May have been Affected by Fraud; Contact BFA Law (Nasdaq:ADMA)GlobeNewswire
- ADMA Biologics Inc (ADMA) Q3 2024 Earnings Call Highlights: Record Revenue and Net Income Surge [Yahoo! Finance]Yahoo! Finance
ADMA
Earnings
- 11/7/24 - Beat
ADMA
Sec Filings
- 11/8/24 - Form SC
- 11/7/24 - Form 10-Q
- 11/7/24 - Form 8-K
- ADMA's page on the SEC website